Michael Clark, vice president of Integrated Marketing at Simmons Foods, was appointed to serve on the advisory board for Namida Lab, a product-stage biotechnology company specializing in the development and commercialization of early cancer detection proteomics tests.
Clark, who has enjoyed a thirty-year career in a variety of sales and marketing roles, graduated from Oklahoma Christian University with a Bachelor of Science degree in Marketing.
Others appointed to serve on the advisory board are:
- Dr. V. Suzanne Klimberg, MD, PhD, who has over 30 years of experience in breast surgical oncology.
- Dr. Steven E. Harms, MD, who is recognized nationally in the area of magnetic resonance imaging (MRI), specifically Breast MRI, and was named “Komen Foundation Scientist of the Year” by Susan G. Komen for the Cure.
- Marcus Osborne is the CEO of RightMove, a nationwide virtual musculoskeletal physical therapy provider.
“A good advisory board is essential for a start-up company. Bringing disruptive healthcare innovations to market is a complicated process. A group of advisors who have done it in the past will allow us to test hypotheses to accelerate the path to market success,” said Omid Moghadam, founder and CEO of Namida.
